Tumor microenvironment and therapeutic response

Wu, Ting, Dai, Yun·2017·Cancer Letters

Cited by (1,000)

Items 801–900 of 1,000

  1. Propofol enhances the sensitivity of glioblastoma cells to temozolomide by inhibiting macrophage activation in tumor microenvironment to down-regulate HIF-1α expression
    Wenbo Zhao, Keming Yun · 2022 · Experimental Cell Research
  2. Mechanical Properties of the Extracellular Environment of Human Brain Cells Drive the Effectiveness of Drugs in Fighting Central Nervous System Cancers
    Mateusz Cieśluk, Katarzyna Pogoda, Ewelina Piktel, Urszula Wnorowska, Piotr Deptuła, Robert Bucki · 2022 · Brain Sciences
  3. Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
    Ying Tan, Miaomiao Liu, Ming Li, Yujuan Chen, Meng Ren · 2022 · Frontiers in Pharmacology
  4. Role of the ubiquitin–proteasome system on macrophages in the tumor microenvironment
    Yue Xiao, Ruiqian Liu, Na Li, Yong Li, Xuan Huang · 2024 · Journal of Cellular Physiology
  5. Enhanced pyroptosis induction with pore-forming gene delivery for osteosarcoma microenvironment reshaping
    Jing‐Jun Nie, Bowen Zhang, Peng Luo, Maoguo Luo, Yuwen Luo, Jingjing Cao, Hong‐Gang Wang, Jianping Mao, Yonggang Xing, Weifeng Liu et al. · 2024 · Bioactive Materials
  6. Identification of RFC4 as a potential biomarker for pan‐cancer involving prognosis, tumour immune microenvironment and drugs
    Lei Yu, Jing Li, Mingyang Zhang, Yu Li, Jing Bai, Pengxia Liu, Jia Yan, Changshan Wang · 2024 · Journal of Cellular and Molecular Medicine
  7. Surface Modification of Mesoporous Silica Nanoparticles as a Means to Introduce Inherent Cancer‐Targeting Ability in a 3D Tumor Microenvironment
    Neeraj Prabhakar, Erica Långbacka, Ezgi Özliseli, Jesse Mattsson, Alaa Mahran, Ilida Suleymanova, Cecilia Sahlgren, Jessica M. Rosenholm, Malin Åkerfelt, Matthias Nees · 2024 · Small Science
  8. Tumor microenvironment: A playground for cells from multiple diverse origins
    Deblina Bharadwaj, Mahitosh Mandal · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  9. Neutrophils in colorectal cancer: mechanisms, prognostic value, and therapeutic implications
    Xingyue Wang, Shukang He, Xiangmei Gong, Shijun Lei, Qianwen Zhang, Junqi Xiong, Yang Liu · 2025 · Frontiers in Immunology
  10. Melanoma cancer stem-like cells: Optimization method for culture, enrichment and maintenance
    Yaiza Jiménez-Martínez, Gloria Ruiz-Alcalá, García Ortega María Belén, Elena López‐Ruiz, Jiménez Gema, Marchal Juan Antonio, García Chaves María Ángel, Houría Boulaiz · 2019 · Tissue and Cell
  11. Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer
    Zhao Zhang, Dongshan Chen, Zeyan Li, Zhao Liu, Lei Yan, Zhonghua Xu · 2020 · BioMed Research International
  12. Current statuses of molecular targeted and immune checkpoint therapies in hepatocellular carcinoma.
    Deqiang Kong, Chen Liu, Xiaolong Miao, Yao Wang, Xianfeng Ding, Weihua Gong · 2020 · PubMed Central
  13. Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma
    Yunhan Shan, Peijun Zhou, Qin Zhou, Lifang Yang · 2022 · Cancers
  14. Oncolytic Viruses as Nanomedicines against the Tumor Microenvironment
    Uzma Zaheer, Neeraja A. Hassain, Banu, Shabeena, Shilu Mathew · 2021 · Biointerface Research in Applied Chemistry
  15. PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
    Zhewen Zheng, Xue Zhang, Jian Bai, Long Long, Di Liu, Yunfeng Zhou · 2022 · Cancer Cell International
  16. GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer
    Yanlong Shi, Mingbo Liu, Hong-ting Wu, Han Ye, Xuan He · 2022 · Disease Markers
  17. Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
    Zhihao Yao, Henghui Zhang, Xuejun Zhang, Zhiyong Zhang, Jirong Jie, Kunfeng Xie, Fei Li, Wanlong Tan · 2022 · Frontiers in Genetics
  18. NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma
    Shiyao Jiang, Jingjing Huang, Hua He, Yueying Liu, Lu Liang, Xiaoyan Sun, Yi Li, Li Cong, Bei Qing, Yiqun Jiang · 2022 · Cancers
  19. Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer
    Yiheng Jiang, Shengbo Huang, Xinqing Zhu, Liang Cheng C, Wenlong Liu, Qiwei Chen, Deyong Yang · 2022 · Journal of Oncology
  20. The Effects of Heat Stress on the Transcriptome of Human Cancer Cells: A Meta-Analysis
    Enzo M. Scutigliani, Fernando Lobo-Cerna, Sergio Mingo Barba, Stephan Scheidegger, Przemek M. Krawczyk · 2022 · Cancers
  21. The Comprehensive Role of High Mobility Group Box 1 (HMGB1) Protein in Different Tumors: A Pan-Cancer Analysis
    Hui Guan, Ming Zhong, Kongyang Ma, Chun Tang, Xiaohua Wang, Muzi Ouyang, Rencai Qin, Jiasi Chen, Enyi Zhu, Ting Zhu et al. · 2023 · Journal of Inflammation Research
  22. An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
    Yu Zhang, Yan Li, Zan Zuo, Ting Li, Ying An, Wenjing Zhang · 2023 · Pathology & Oncology Research
  23. Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM
    Yuyao Liu, Haoxue Zhang, Yan Mao, Yangyang Shi, Xu Wang, Shaomin Shi, Delin Hu, Shengxiu Liu · 2023 · Frontiers in Immunology
  24. Targeted therapy for head and neck squamous cell carcinoma microenvironment
    Zhaomeng Guo, Kang Li, Peng Liu, Xiangmin Zhang, Jie Lv, Xianhai Zeng, Peng Zhang · 2023 · Frontiers in Medicine
  25. PLK1: a promising and previously unexplored target in double-hit lymphoma
    Quais N. Hassan, Lapo Alinari, John C. Byrd · 2018 · Journal of Clinical Investigation
  26. Head and neck cancer exosomes drive microRNA-mediated reprogramming of local neurons
    Patrick J. Hunt, Moran Amit · 2020 · Extracellular Vesicles and Circulating Nucleic Acids
  27. Establishment of a Prognostic Model of Lung Adenocarcinoma Based on Tumor Heterogeneity
    Pengdou Zheng, Huojun Zhang, Weiling Jiang, Lingling Wang, Lu Liu, Yuhao Zhou, Ling Zhou, Huiguo Liu · 2022 · Frontiers in Molecular Biosciences
  28. Molecular mechanisms and therapies of immune checkpoint inhibitor associated myocarditis: Update on recent developments
    Jiaqi Li, Lin Chen, Xiaolin Liu, Mei Zhang, Xiaoling Liu · 2025 · Seminars in Cancer Biology
  29. Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy
    Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen · 2026 · BMEMat
  30. Integrating single-cell and spatial transcriptomics to dissect mast-cell heterogeneity and arginine-metabolism-associated markers in BRCA
    Mengli Gao, Yuge Ran, Juan Qi, Xiao Han, Yali Wei, K. Wang, Xiaoxi Wu, Chengcheng Sun, Yanhong Li, W Wang et al. · 2026 · Neoplasia
  31. The Mechanism of Alisol B23 Acetate Inhibiting Lung Cancer: Targeted Regulation of CD11b/CD18 to Influence Macrophage Polarization
    Yingna Chen, Jieya Lu, Zhihao Xie, Jialing Tang, Xuejiao Lian, Xiuwen Li · 2022 · Drug Design Development and Therapy
  32. Transcriptomics and metabolomics reveal changes in the regulatory mechanisms of osteosarcoma under different culture methods in vitro
    Sen Yang, Zhi Tian, Yi Feng, Kun Zhang, Yongchun Pan, Yuan Li, Zhichao Wang, Wenhao Wei, Xiaochen Qiao, Ruhao Zhou et al. · 2022 · BMC Medical Genomics
  33. CAF signature predicts the prognosis of colorectal cancer patients: A retrospective study based on bulk RNA sequencing and single-cell RNA sequencing data
    Liang Chen, Dongze Ji, Feng Qin, Gang Chen · 2023 · Medicine
  34. By using machine learning and in vitro testing, SERPINH1 functions as a novel tumorigenic and immunogenic gene and predicts immunotherapy response in osteosarcoma
    Guang Xia, Song Ji Wu, Ke Luo, Xiaoyu Cui · 2023 · Frontiers in Oncology
  35. Stimulus‐responsive nano lipidosome for enhancing the anti‐tumour effect of a novel peptide Dermaseptin‐PP
    Changhai Wang, Ziyi Dong, Qing Zhang, Mingxue Guo, Wenjun Hu, Shuang Dong, Jakkree Tangthianchaichana, Yang Lu, Shouying Du · 2023 · IET Nanobiotechnology
  36. Identifying potential targets for lung cancer intervention by analyzing the crosstalk of cancer‐associated fibroblasts and immune and metabolism microenvironment
    Shiyou Wei, Minwei Bao, Yuming Zhu, Wentian Zhang, Lei Jiang · 2023 · Environmental Toxicology
  37. Prognostic Implications of LRP1B and Its Relationship with the Tumor-Infiltrating Immune Cells in Gastric Cancer
    Rui Wang, Guangtao Zhang, Xiaohong Zhu, Yan Hua Xu, Nida Cao, Zhaoyan Li, Han Chen, Mengmeng Qin, Yumiao Shen, Jiahuan Dong et al. · 2023 · Cancers
  38. Prolyl isomerase Pin1 sculpts the immune microenvironment of colorectal cancer
    Yang Li, Zhongnan Yuan, Linlin Wang, Jing Hua Yang, Pei Pu, Yunting Le, XianWei Chen, Chongyang Wang, Yating Gao, Yi Liu et al. · 2024 · Cellular Signalling
  39. Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes
    Xinglei Liu, Liang Liu, Anyi Wu, Shilu Huang, Zhipeng Xu, Xiaopei Zhang, Zengyang Li, Haoran Li, Jun Dong · 2024 · CNS Neuroscience & Therapeutics
  40. Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy
    Shiyi Tang, Yun Zhang, Shengmei Huang, Tengfei Zhu, Xiaojing Huang · 2024 · Frontiers in Immunology
  41. Systematic pan‐cancer analysis insights into ICAM1 as an immunological and prognostic biomarker
    Chunjiao Yang, Bingqiang Ni, Ling Shen, Zhenlong Li, Lu Zhou, Huayun Wu, Yuzhe Zhang, Ling Liu, Jiao Liu, Liansheng Tian et al. · 2024 · The FASEB Journal
  42. The role of cuproptosis in gastric cancer
    Yixian Li, Wenhao Sun, Shaolin Yuan, Xinxin Liu, Ziqi Zhang, Renjun Gu, Pengfei Li, Xin Gu · 2024 · Frontiers in Immunology
  43. Curcumin and Its Potential to Target the Glycolytic Behavior of Lactate-Acclimated Prostate Carcinoma Cells with Docetaxel
    Dongsic Choi, Jung‐Min Lee, Su-Hak Heo, M. K. Cho, Hae-Seon Nam, Sang‐Han Lee, Yoon‐Jin Lee · 2024 · Nutrients
  44. Prognostic value and immune infiltration of a tumor microenvironment-related PTPN6 in metastatic melanoma
    Ruoyao Sun, Shuqiang Wei, Ying Yu, Zhuo Wang, Tonghao Yao, Yining Zhang, Luping Cui, Xu Ma · 2024 · Cancer Cell International
  45. Potential role of P4HB in the tumor microenvironment and its clinical prognostic value: a comprehensive pan-cancer analysis and experimental validation with a focus on KIRC
    Linxue Zhang, Yu-wei Li, Tianyi Xie, Ke Wei Sun, Xiang Huang, Wei Xiong, RuiJi Liu · 2025 · Cancer Cell International
  46. Carvedilol sensitizes chemotherapy by targeting STING to boost anti-tumor immunity
    Yifang Dang, Mingtong Ma, Yan Wang, Mengmeng Zhao, Yajuan Cao, Hang Su, Tianhao Liu, Mengge Zheng, Jiani Gao, Xiangyang Wu et al. · 2025 · Cell Reports
  47. Targeting the Enhanced Sensitivity of Radiotherapy in Cancer: Mechanisms, Applications, and Challenges
    Yuanyuan Zhao, Fangqin Tan, Jiajia Zhao, Shuchang Zhou, Yao Luo, Gong Chen · 2025 · MedComm
  48. Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma
    Muzi Li, Qiong Li, Chen Zou, Qin Huang, Yanlin Chen · 2025 · Frontiers in Oncology
  49. Emerging Immunotherapy Targets in Early Drug Development
    D. Morchón Araujo, Greta Catani, Oriol Mirallas, Giulia Pretelli, Vicky Sánchez-Pérez, María Vieito, Irene Braña, Ricardo Pujol‐Borrell, Elena Garralda, Alberto Hernando‐Calvo · 2025 · International Journal of Molecular Sciences
  50. Evaluation of immune infiltrating of thyroid cancer based on the intrinsic correlation between pair-wise immune genes
    Meng Jia, Zhuyao Li, Mengjiao Pan, Mei Tao, Xiubo Lu, Liu Yang · 2020 · Life Sciences
  51. Emerging roles of steroid receptor coactivators in stromal cell responses
    Aarti D. Rohira, David Michael Lonard, Bert W. O’Malley · 2020 · Journal of Endocrinology
  52. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
    Guangzhao Huang, Ze-qun Chen, Juan Wu, Tingru Shao, Chen Zou, Yilong Ai, Xiaozhi Lv · 2021 · Journal of Immunology Research
  53. Biotin-Targeted Multifunctional Nanoparticles Encapsulating 10-Hydroxycamptothecin and Apoptin Plasmid for Synergistic Hepatocellular Carcinoma Treatment
    Zhuanxia He, Ke Bao, Jianbo Jian, Yuqing Zhao, Zhihan Jian, Chunhong Hu, Xiujun Gao · 2021 · ACS Applied Polymer Materials
  54. Pan-cancer analyses identify DCBLD2 as an oncogenic, immunological, and prognostic biomarker
    Pan Xie, Junyan Liu, Han Yan, Zhibin Wang, Shilong Jiang, Xi Li, Zhaoqian Liu · 2022 · Frontiers in Pharmacology
  55. Integrated and dual-responsive lipopeptide nanovector with parallel effect to tumor and micro-environment regulation by efficient gene and drug co-delivery
    Xiaobing Chen, Huan Yang, Xu Song, Hong Liang, Yu Wei, Jiao Lu, Matthias Barz, Rongrong Jin, Yu Nie · 2022 · Chinese Chemical Letters
  56. Oncolytic virotherapy against the tumor microenvironment and its potential in pancreatic cancer
    Yalei Zhang, Ye Li, Kun Chen, Ling Qian, Peng Wang · 2022 · Journal of Cancer Research and Therapeutics
  57. Proteomics analysis of cancer tissues identifies IGF2R as a potential therapeutic target in laryngeal carcinoma
    Bing Liu, Yuqiang Hu, Lixia Wan, Luan Wang, Liangjun Cheng, Hai Sun, Yaran Liu, Di Wu, Jiefei Zhu, Xiu Hong et al. · 2022 · Frontiers in Endocrinology
  58. Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma
    Yichen Yang, Ben Ma, Litao Han, Weibo Xu, Xiaoxue Du, Wenjun Wei, Tian Liao, Qinghai Ji, Ning Qu, Yu Wang · 2022 · Frontiers in Genetics
  59. Employing machine learning using ferroptosis-related genes to construct a prognosis model for patients with osteosarcoma
    Hui Huang, Zhifang Ye, Zhengzhao Li, Bo Wang, Ke Li, Kai Zhou, Huiyuan Cao, Jiaxuan Zheng, Guangji Wang · 2023 · Frontiers in Genetics
  60. Identification of immune cell infiltration landscape for predicting prognosis of colorectal cancer
    Xueqian Wu, Jianxia Li, Yuanzhe Zhang, Yi Cheng, Zehua Wu, Weixiang Zhan, Yanhong Deng · 2022 · Gastroenterology report
  61. Pan-cancer landscape of CENPO and its underlying mechanism in LUAD
    Tongdong Shi, Zaoxiu Hu, Li Tian, Yanlong Yang · 2023 · Respiratory Research
  62. Three-Dimensional Spheroids for Cancer Research
    Melissa Anne Tutty, Adriele Prina‐Mello · 2023 · Methods in molecular biology
  63. A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma
    Yangxia Chen, Di Hu, Fang Wang, Cheng Huang, Hesong Xie, Ling Jin · 2023 · Aging
  64. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology
    Mark Gray, James Meehan, Arran Turnbull, Carlos Martínez-Pérez, Charlene Kay, Lisa Y. Pang, David J. Argyle · 2020 · Frontiers in Veterinary Science
  65. Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
    Jing Guo, WU Jiang⁃ping, Qiuyue Fang, Yulou Liu, Chuzhong Li, Yazhuo Zhang · 2021 · Frontiers in Genetics
  66. Identification of new biomarkers in immune microenvironment of testicular germ cell tumour
    Yuxuan Song, Xiangjie Qi, Jiaqi Kang, Xiao Wang, Ningjing Ou, Jun Wei Zhu, Shangren Wang, Xiaoqiang Liu · 2021 · Andrologia
  67. Prognostic signature of ovarian cancer based on 14 tumor microenvironment-related genes
    Xiazi Nie, Lina Song, Xiaohua Li, Yirong Wang, Bo Qu · 2021 · Medicine
  68. Progesterone receptor gene serves as a prognostic biomarker associated with immune infiltration in gastric cancer: a bioinformatics analysis
    Manyu Li, Cheng Zhou · 2021 · Translational Cancer Research
  69. Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy
    Xiaobo Zheng, Yong Gao, Chune Yu, Guiquan Fan, Pengwu Li, Ming Zhang, Jing Yu, Mingqing Xu · 2021 · Scientific Reports
  70. Development of a prognostic signature of patients with esophagus adenocarcinoma by using immune-related genes
    Xiangxin Zhang, Yang Liu, Ming Kong, Jian Ma, Yutao Wei · 2021 · BMC Bioinformatics
  71. Overexpression and diagnostic significance of INTS7 in lung adenocarcinoma and its effects on tumor microenvironment
    Xiang Li, Yiyong Yao, Jin-Xian Qian, Guomin Jin, Gang Zeng, Hongmei Zhao · 2021 · International Immunopharmacology
  72. Multidimensional Analysis of the Role of Charged Multivesicular Body Protein 7 in Pan-Cancer
    Guo Yu, Jian Shi, Zeyun Zhao, Min Wang · 2021 · International Journal of General Medicine
  73. Smart Drug Delivery Strategies for Cancer Therapy
    Carlos Miguel López Mendoza, Luz Eugenia Alcántara-Quintana · 2022 · Frontiers in Nanotechnology
  74. Landscape of T Cells in NK-AML(M4/M5) Revealed by Single-Cell Sequencing
    Wenqi Wu, Xiaolin Liang, Huiqun Li, Xiaoke Huang, Chengyao Wan, Qiongni Xie, Zhenfang Liu · 2022 · Journal of Leukocyte Biology
  75. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma
    Jian Cheng, Fang Chen, Yufeng Cheng · 2022 · Cells
  76. Combined Cancer Immunotheranostic Nanomedicines: Delivery Technologies and Therapeutic Outcomes
    Tasneem Nasser, Rawan Adel, Abdelrahman Badr, Mohamed Teleb, Adnan A. Bekhit, Kadria A. Elkhodairy, Ahmed S. Abdelhamid, Ahmed O. Elzoghby · 2023 · ACS Omega
  77. Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors
    Han Qiao, Hong Xia Yin, Yan Feng, Huaping Tang · 2022 · Frontiers in Immunology
  78. Circular RNA-related CeRNA network and prognostic signature for patients with oral squamous cell carcinoma
    Yaodong He, Dengcheng Yang, Yun‐Shan Li, Junwei Xiang, Liecheng Wang, Yuanyin Wang · 2022 · Frontiers in Pharmacology
  79. Neutrophil‑to‑lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma
    Moyuru Yamada, Koji Tanaka, Makoto Yamasaki, Kotaro Yamashita, Tomoki Makino, Takuro Saito, Tsuyoshi Takahashi, Yukinori Kurokawa, Masaaki Motoori, Yutaka Kimura et al. · 2022 · Oncology Letters
  80. High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis
    Pu Lei, Mengzhao Zhang, Yan Li, Ziming Wang · 2023 · Frontiers in Genetics
  81. SFPQ promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with poor prognosis.
    You‐Yu Lin, Wenting Zhong, Qili Lin, Yan Ye, ShengZhao Li, Hui Chen, Hongxia Liu, Luyun Xu, Wei Zhuang, Shaoqing Chen et al. · 2023 · PubMed Central
  82. Fabrication of Graphitic Carbon Nitride/Barium Hydroxide Nanocomposite as an Effective Anticancer Agent against MCF‐7 Cell Lines
    Saumya, Khalid Imtiyaz, M. Moshahid A. Rizvi, Bhavani Prasad Nenavathu · 2023 · ChemistrySelect
  83. Integration of O 2 -economised tumour-targeted photosensitive magnetic nanomaterials in the diagnosis and therapy of gastric cancer
    Jinrong SiTu, Yingying Yang, Lingle Zhang, Hongzhang Yan, Yingsheng Cheng · 2024 · RSC Advances
  84. Jiedu Xiaozheng Yin Inhibits the Progression of Colitis Associated Colorectal Cancer by Stimulating Macrophage Polarization Towards an M1 Phenotype via the TLR4 Pathway
    Haiqin Liu, Shuo Yan, Ruiming Yang, Caidi Huang, Kangyue Guo, Shi Wang, Yunmei Huang, Dongyi Shen, Ying Lin, Zhiyun Cao et al. · 2024 · Integrative Cancer Therapies
  85. Annexin A2: the feasibility of being a therapeutic target associated with cancer metastasis and drug resistance in cancer microenvironment
    Song Weijie · 2024 · Discover Oncology
  86. The regulatory role of integrin in gastric cancer tumor microenvironment and drug resistance
    Songlin Wu, Abdel Nasser B. Singab, Guimei Lin, Yulu Wang, Huaibo Zhu, Guang Yang, Jiaqi Chen, Jiaxuan Li, Peiyao Li, Di Zhao et al. · 2025 · Progress in Biophysics and Molecular Biology
  87. Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
    Lin Tang, Shao‐Cong Peng, Xiao‐Wan Zhuang, Yan He, Yuxiang Song, Hao Nie, Can‐Can Zheng, Zhenyu Pan, Alfred King-yin Lam, Ming‐Liang He et al. · 2025 · MedComm – Oncology
  88. Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy
    Bandar E. Al‐Dhubiab, Rashed M. Almuqbil, Anroop Balachandran Nair · 2025 · Pharmaceuticals
  89. Research progress of colorectal cancer in genomic and transcriptomic at multi-level
    Qinglian Wen, Shuangyan Han, Yongxia Cui · 2025 · Frontiers in Genetics
  90. Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy
    Liting Wang, Hao Fu, Jiangtao Lin, Meng Liang Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan · 2025 · Aggregate
  91. A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity
    Yi Jiang, Hong-li Liao, Liya Chen · 2021 · Disease Markers
  92. Identification of Hub lncRNAs Along With lncRNA-miRNA-mRNA Network for Effective Diagnosis and Prognosis of Papillary Thyroid Cancer
    Haiyan Li, Feng Liu, Xiaoyang Wang, Menglong Li, Zhihui Li, Yongmei Xie, Yanzhi Guo · 2021 · Frontiers in Pharmacology
  93. Recent research advances of the biomimetic tumor microenvironment and regulatory factors on microfluidic devices: A systematic review
    Hui Xu, Cheng Cheng, Weidong Le · 2022 · Electrophoresis
  94. SOX8 promotes cetuximab resistance via HGF/MET bypass pathway activation in colorectal cancer
    Haiyan Piao, Jinglei Qu, Yun-Peng Liu · 2022 · Cancer Chemotherapy and Pharmacology
  95. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia
    Fang Cheng, Qiang Li, Jinglin Wang, Liu Wang, Weiming Li, Fang Zeng · 2022 · Disease Markers
  96. Review article epithelial to mesenchymal transition‑associated microRNAs in breast cancer
    Hossein Javdani, Homa Mollaei, Farzaneh Karimi, Shiva Mahmoudi, Ali Farahi, Mohamad Javad Mirzaei-Parsa, Arman Shahabi · 2022 · Molecular Biology Reports
  97. Complex in vitro 3D models of digestive system tumors to advance precision medicine and drug testing: Progress, challenges, and trends
    Shenglei Song, Bo Li, Mariana R. Carvalho, Huijun Wang, Deli Mao, Jitao Wei, Wei Chen, Zhi-Hui Weng, Yangchao Chen, Chu‐Xia Deng et al. · 2022 · Pharmacology & Therapeutics
  98. Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
    Paulina A. Cerro, Marta Mascaraque, María Gallego-Rentero, Manuel Almenara‐Blasco, Jimena Nicolás Morala, J.L. Santiago, Salvador González, Tamara Gracia‐Cazaña, Ángeles Juarranz, Yolanda Gilaberte · 2022 · Frontiers in Oncology
  99. Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation
    Arianna Scagliotti, Laura Capizzi, Marina Elena Cazzaniga, Alice Ilari, Marco De Giorgi, Nicoletta Cordani, Matteo Gallazzi, Antonino Bruno, Giuseppe Pelosi, Adriana Albini et al. · 2022 · Frontiers in Oncology
  100. A five-protein prognostic signature with GBP2 functioning in immune cell infiltration of clear cell renal cell carcinoma
    Kun Meng, Yuying Li, Dan-Ya Liu, Liling Hu, Yunlong Pan, Chris Zhiyi Zhang, Qing‐Yu He · 2023 · Computational and Structural Biotechnology Journal